rel-Licogliflozin is a sodium glucose cotransporter (SGLT) inhibitor, specifically targeting SGLT1 and SGLT2. This compound demonstrates significant biological activity in glucose transport modulation, making it valuable for research into diabetes and other metabolic disorders. Its role in disrupting glucose reabsorption in the kidneys has potential applications in developing therapeutic strategies for hyperglycemia management.
rel-Licogliflozin is a sodium glucose cotransporter (SGLT) inhibitor, specifically targeting SGLT1 and SGLT2. This compound demonstrates significant biological activity in glucose transport modulation, making it valuable for research into diabetes and other metabolic disorders. Its role in disrupting glucose reabsorption in the kidneys has potential applications in developing therapeutic strategies for hyperglycemia management.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
